GSK logo

GSK GSK plc

New York Stock Exchange · Drug Manufacturers - General · Healthcare

$47.76
-0.06 (-0.13%)

GSK plc is a global pharmaceutical and healthcare company, deeply involved in the research, development, production, and commercialization of a diverse range of medicinal and wellness products. Its operations span the United Kingdom, the United States, and numerous other international markets. The company structures its operations across four primary divisions: Pharmaceuticals, Pharmaceutical R&D,…

Market Cap: $95.73Bwww.gsk.com

Price

No data yet.

Social Signal Score

50
5d
55
1 mentions
—
30d
47
20 mentions
—
60d
47
35 mentions
—
90d
51
52 mentions
—
news: 52

Analyst Ratings

29 analysts
Holdconsensus
Strong Buy 0Buy 9Hold 16Sell 4Strong Sell 0
Avg price target$57.95+21.3%
Low $55.9Median $57.95High $60
Current Consensus

Revenue

$8.82B+16.23%
$5.84B$7.07B$8.30B$9.53B
Dec 2016Sep 2026

Analyst Estimates

FY2025
$3.37
$3.32–$3.43
4 analysts
FY2026
$3.62+8% YoY
$3.55–$3.73
7 analysts
FY2027
$3.77+4% YoY
$3.65–$3.89
7 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Luke Victor Miels
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
66,841
Beta
0.28
Country
GB
Piotroski score
8 / 9 (Strong)
Altman Z-score
1.78
www.gsk.com